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background:  Current tools to identify individuals at risk for sudden cardiac death (SCD) are insufficient, and improved risk stratification 
strategies are needed at a population level. Electrocardiographic (ECG) abnormalities of atrial depolarization in lead V1 have previously 
been associated with SCD, but it is not known whether atrial repolarization abnormalities such as PR segment depression (PRD) may also 
predict SCD.
Methods:  Baseline 12-lead ECGs were reviewed from the Atherosclerosis Risk in Communities (ARIC) cohort. Individuals with coronary 
heart disease, prior stroke, heart failure, atrial fibrillation, pacemakers, and a QRS duration ≥ 120 ms were excluded. A total of 13,278 
participants (mean age 53.9 ± 5.7 y, 56.5% female, 73.6% white) were included. PR deviation was automatically measured in V1 as the 
amplitude of the ECG signal at the QRS onset relative to the isoelectric baseline, defined as the end of the TP segment. PRD was defined 
as any negative PR segment deviation. Adjudicated SCD served as the primary outcome.
results:  There were 182 cases of SCD (1.4%) after a median of 14 years of follow-up. The prevalence of PRD in V1 was 60.1% (n = 
7974) in the cohort and 63.2% (n = 115) in those with SCD. PRD in V1 was significantly associated with SCD in a multivariable Cox model 
adjusted for age, sex, race, and study center (HR 1.18 per standard deviation change, 95% CI 1.02 - 1.36, p = 0.03). When additional 
clinical predictors (body mass index, total cholesterol, triglycerides, HDL, leisure activity index, diabetes mellitus, smoking status, systolic 
blood pressure, use of anti-hypertensive medications, and use of QT-prolonging medications) and ECG predictors (QTc interval, heart rate, 
ECG left ventricular hypertrophy, QRS duration, PR interval duration, averaged P wave duration, P wave axis, and P prime deep terminal 
negativity in V1) were included in the model, the association remained significant (HR 1.16 per standard deviation change, 95% CI 1.01 - 
1.33). A dose-response effect was noted, and a similar association was observed when V2 and V3 were analyzed.
Conclusion:  PRD in lead V1 on the resting ECG is associated with SCD in the general population, and it may add to SCD risk 
stratification.
